Skip to Main Content

Author Details

Jeremy J Rose
National Cancer Institute
2000
32
20
PMIDPaper TitleJournal TitlePublished Year
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
35114411Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.Transplant Cell Ther2022
35114411Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.Transplant Cell Ther2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
32976576A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.Blood2021
34335560Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.Front Immunol2021
32976576A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.Blood2021
34433916Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.Bone Marrow Transplant2021
35005541Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.iScience2021
35005541Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.iScience2021
34433916Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.Bone Marrow Transplant2021
34335560Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.Front Immunol2021
31493539Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.Biol Blood Marrow Transplant2020
31959992Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.Nat Med2020
31903638Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.Am J Hematol2020
31493539Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.Biol Blood Marrow Transplant2020
31903638Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.Am J Hematol2020
31959992Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.Nat Med2020
30470981Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.J Clin Immunol2019
30470981Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.J Clin Immunol2019
29812997T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.J Clin Oncol2018
29812997T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.J Clin Oncol2018
27796910Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.AAPS J2017
28851699An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Blood2017
28756593Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.J Neurooncol2017
27796910Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.AAPS J2017
28756593Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.J Neurooncol2017
28851699An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Blood2017
26811520Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.J Clin Oncol2016
26811520Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.J Clin Oncol2016
27412889T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.Blood2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27412889T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.Blood2016
25532725Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Stem Cells2015
25532725Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Stem Cells2015
25771402Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.Biol Blood Marrow Transplant2015
25771402Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.Biol Blood Marrow Transplant2015
24577531Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.Leukemia2014
24577531Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.Leukemia2014
23344265B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.Clin Cancer Res2013
24055823Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.Blood2013
23344265B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.Clin Cancer Res2013
24055823Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.Blood2013
22289893Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.Blood2012
22289893Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.Blood2012
18311596Cholesterol is obligatory for polarization and chemotaxis but not for endocytosis and associated signaling from chemoattractant receptors in human neutrophils.J Biomed Sci2008
18500349Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.Nat Med2008
  • 1 - 50 of 64

Recommended Authors

City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Huntsman Cancer Institute, University of Utah
Career Start Year 2009
Number of shared co-authors 0
Adaptive Biotechnologies Corp
Career Start Year 2005
Number of shared co-authors 2
Medical University of Bialystok
Career Start Year 2001
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 0
Purdue University
Career Start Year 1999
Number of shared co-authors 0
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 2
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 2
University of California san francisco
Career Start Year 1990
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 1987
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1985
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1984
Number of shared co-authors 0
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 3
Genentech Inc.
Career Start Year 1974
Number of shared co-authors 2
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

National Cancer Institute
Co-authored papers 20
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 15
National Cancer Institute, National Institutes of Health
Co-authored papers 14
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 5
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Liaoning Normal University
Co-authored papers 3
National Institute of Dental and Craniofacial Research
Co-authored papers 3
Center for Cancer Research, National Cancer Institute.
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Duke University
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Rutgers Robert Wood Johnson Medical School
Co-authored papers 2
University of Nebraska Medical Center (UNMC)
Co-authored papers 1
Duke University Medical Center
Co-authored papers 1
UNC School of Medicine, The University of North Carolina at Chapel Hill
Co-authored papers 1
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
The University of North Carolina School of Medicine
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1